Thoughts and strategies on the diagnosis and treatment of metabolic diseases in offspring after organ transplantation
10.3760/cma.j.cn421203-20240712-00163
- VernacularTitle:器官移植后代谢性疾病诊治的思考与策略
- Author:
Chun XU
1
;
Ning LI
;
Yujian NIU
Author Information
1. 中国人民解放军总医院第三医学中心内分泌科，北京 100039
- Publication Type:Journal Article
- Keywords:
Organ transplantation;
Post-transplant diabetes mellitus;
Metabolic Disorders;
Hyperlipidemia;
Hyperuricemia;
Management
- From:
Chinese Journal of Organ Transplantation
2025;46(8):581-586
- CountryChina
- Language:Chinese
-
Abstract:
The incidence of metabolic disorders is relatively high among transplant recipients and is closely related to the use of immunosuppressive agents. Metabolic diseases can trigger or accelerate the progression of cardiovascular conditions, becoming an important factor affecting long-term survival after transplantation. This article discusses the reasons for the high incidence of post-transplant metabolic disorders, and introduces the management strategies for post-transplant diabetes, dyslipidemia, and hyperuricemia, including early screening, timely diagnosis, and continuous management. It also highlights current challenges in the management of metabolic disorders after organ transplantation in China, such as insufficient interdisciplinary collaboration, lack of research data, and low awareness among recipients. It is recommended to establish a multidisciplinary follow-up system, improve the general medical capabilities of follow-up teams, and achieve precise management of transplant recipients.
